D.J. St. Germain’s Boston Scientific BSX Stock Holding History

D.J. St. Germain’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.9K	Sell	1,262 -223	-15%	-$12.1K	﹤0.01%	463
2026 Q1	$93.2K	Hold	1,485	–	–	﹤0.01%	375
2025 Q4	$142K	Sell	1,485 -438	-23%	-$42.9K	0.01%	361
2025 Q3	$188K	Hold	1,923	–	–	0.01%	311
2025 Q2	$207K	Hold	1,923	–	–	0.01%	293
2025 Q1	$194K	Hold	1,923	–	–	0.01%	274
2024 Q4	$172K	Hold	1,923	–	–	0.01%	297
2024 Q3	$161K	Hold	1,923	–	–	0.01%	288
2024 Q2	$148K	Buy	1,923 +143	+8%	+$10.5K	0.01%	290
2024 Q1	$122K	Hold	1,780	–	–	0.01%	303
2023 Q4	$103K	Buy	1,780 +1,700	+2,125%	+$90.7K	0.01%	319
2023 Q3	$4.22K	Hold	80	–	–	﹤0.01%	603
2023 Q2	$4.33K	Buy	+80	New	+$4.18K	﹤0.01%	599

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.J. St. Germain's BSX Position: Q2 2026 in Review

D.J. St. Germain reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $12.1K and leaving 1,262 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

D.J. St. Germain first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $207K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

D.J. St. Germain held 1,262 shares of Boston Scientific worth $53.9K as of Q2 2026.
D.J. St. Germain sold 223 Boston Scientific shares in Q2 2026, an estimated $12.1K.
Boston Scientific made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #463 holding.
D.J. St. Germain first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
D.J. St. Germain's Boston Scientific position peaked at $207K in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.